Anteilseigner
Snehal S. Patel (41,35 %) Michael Guy Weiner (24,51 %) David B. McWilliams,
MBA (4,83 %) Kenneth Hallock,
MBA (3,09 %) Jaye L. Thompson,
PhD (2,03 %) The Vanguard Group, Inc. (1,70 %) F. Joseph Daugherty,
III,
MD (0,70 %) Degroof Petercam Asset Services SA (0,68 %) Columbia Management Investment Advisers LLC (0,49 %) BlackRock Fund Advisors (0,43 %) Renaissance Technologies LLC (0,42 %) Geode Capital Management LLC (0,36 %) GSA Capital Partners LLP (0,36 %) Millennium Management LLC (0,15 %) SSgA Funds Management, Inc. (0,10 %) Squarepoint OPS LLC (0,09 %) Bank of America, NA (Private Banking) (0,03 %) Newbridge Financial Services Group, Inc. (0,01 %) Qube Research & Technologies Ltd. (0,01 %)
Kontakt
Greenwich Lifesciences Inc.